93 related articles for article (PubMed ID: 30168061)
1. Heterogeneous Expression of Embryonal Development Master Regulator SOX9 in Patients with Pancreatic Cancer.
Kondratyeva LG; Chernov IP; Zinovyeva MV; Egorov VI; Kopantzev EP; Sverdlov ED
Dokl Biochem Biophys; 2018 Jul; 481(1):208-211. PubMed ID: 30168061
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
4. Expression of master regulatory genes of embryonic development in pancreatic tumors.
Kondratyeva LG; Chernov IP; Zinovyeva MV; Kopantzev EP; Sverdlov ED
Dokl Biochem Biophys; 2017 Jul; 475(1):250-252. PubMed ID: 28864900
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of expression of mater genes SOX9, FOXA2, and GATA4 in pancreatic cancer cells stimulated with TGFβ1 epithelial-mesenchymal transition.
Kondratyeva LG; Sveshnikova AA; Grankina EV; Chernov IP; Kopantseva MR; Kopantzev EP; Sverdlov ED
Dokl Biochem Biophys; 2016 Jul; 469(1):257-9. PubMed ID: 27599506
[TBL] [Abstract][Full Text] [Related]
6. SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties.
Deng W; Vanderbilt DB; Lin CC; Martin KH; Brundage KM; Ruppert JM
J Cell Sci; 2015 Mar; 128(6):1123-38. PubMed ID: 25632159
[TBL] [Abstract][Full Text] [Related]
7. Variable Effects of Growth Factors on Developmental Gene Expression in Pancreatic Cancer Cells.
Gnatenko DA; Kopantzev EP; Sverdlov ED
Dokl Biochem Biophys; 2018 Jul; 481(1):217-218. PubMed ID: 30168063
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic fine-tuning of NF-κB-Sox9 circuitry in cancer stem cells.
Jazirehi AR; Torres-Collado AX
Epigenomics; 2013 Aug; 5(4):363-64. PubMed ID: 24303554
[No Abstract] [Full Text] [Related]
10. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer.
Panza A; Pazienza V; Ripoli M; Benegiamo G; Gentile A; Valvano MR; Augello B; Merla G; Prattichizzo C; Tavano F; Ranieri E; di Sebastiano P; Vinciguerra M; Andriulli A; Mazzoccoli G; Piepoli A
Biochim Biophys Acta; 2013 Aug; 1833(8):1853-65. PubMed ID: 23583560
[TBL] [Abstract][Full Text] [Related]
11. Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Raspaglio G; Petrillo M; Martinelli E; Li Puma DD; Mariani M; De Donato M; Filippetti F; Mozzetti S; Prislei S; Zannoni GF; Scambia G; Ferlini C
Gene; 2014 Jun; 542(2):173-81. PubMed ID: 24661907
[TBL] [Abstract][Full Text] [Related]
12. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
Richtig G; Aigelsreiter A; Schwarzenbacher D; Ress AL; Adiprasito JB; Stiegelbauer V; Hoefler G; Schauer S; Kiesslich T; Kornprat P; Winder T; Eisner F; Gerger A; Stoeger H; Stauber R; Lackner C; Pichler M
PLoS One; 2017; 12(11):e0187814. PubMed ID: 29121666
[TBL] [Abstract][Full Text] [Related]
13. SOX9 drives WNT pathway activation in prostate cancer.
Ma F; Ye H; He HH; Gerrin SJ; Chen S; Tanenbaum BA; Cai C; Sowalsky AG; He L; Wang H; Balk SP; Yuan X
J Clin Invest; 2016 May; 126(5):1745-58. PubMed ID: 27043282
[TBL] [Abstract][Full Text] [Related]
14. SOX9 expression increases with malignant potential in tumors from patients with neurofibromatosis 1 and is not correlated to desert hedgehog.
Carbonnelle-Puscian A; Vidal V; Laurendeau I; Valeyrie-Allanore L; Vidaud D; Bièche I; Leroy K; Lantieri L; Wolkenstein P; Schedl A; Ortonne N
Hum Pathol; 2011 Mar; 42(3):434-43. PubMed ID: 21193222
[TBL] [Abstract][Full Text] [Related]
15. The dose-dependent effect of SOX9 and its incidence in colorectal cancer.
Prévostel C; Blache P
Eur J Cancer; 2017 Nov; 86():150-157. PubMed ID: 28988015
[TBL] [Abstract][Full Text] [Related]
16. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
Qian Y; Xia S; Feng Z
Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.
Shakhova O; Cheng P; Mishra PJ; Zingg D; Schaefer SM; Debbache J; Häusel J; Matter C; Guo T; Davis S; Meltzer P; Mihic-Probst D; Moch H; Wegner M; Merlino G; Levesque MP; Dummer R; Santoro R; Cinelli P; Sommer L
PLoS Genet; 2015 Jan; 11(1):e1004877. PubMed ID: 25629959
[TBL] [Abstract][Full Text] [Related]
19. [SRY and SOX9: the main genetic factors of mammalian sex determination].
Kozhukhar' VG
Tsitologiia; 2012; 54(5):390-404. PubMed ID: 22827036
[TBL] [Abstract][Full Text] [Related]
20. SOX9: A genomic view of tissue specific expression and action.
Symon A; Harley V
Int J Biochem Cell Biol; 2017 Jun; 87():18-22. PubMed ID: 28323209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
